Capricor therapeutics, inc. (CAPR)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-7,641

-15,191

2,431

-18,806

-12,857

-6,216

-8,891

-2,071

-4,884

Adjustments to reconcile net loss to net cash used in operating activities:
Sub-award payable, related party

-

-

-

-

-

-

-

-5

-

Accrued royalties

-

-

-

-

-

-

-

0

-

Accrued interest

-

-

398

344

246

200

58

0

-

CIRM liability

-

-

276

3,100

-

-

-

-

-

CIRM liability

-

-

-

-

0

-

-

-

-

Deferred revenue

-

-

-1,367

-3,190

-3,776

8,333

-

-

-

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

0

-

Note discount arising from beneficial conversion feature

-

-

-

-

-

-

-

-

0

Loss on disposal of fixed asset

-2

0

-

-

-

-

-

-

-1

Gain on sale of property and equipment

-

-

-

-

-

-

-

0

-

Depreciation and amortization

171

157

144

125

110

41

26

20

7

Warrant liability

-

-

-

-

-

-

-

-

0

Write-off of intangible assets

-

-

-

-

-

-

-

-

0

Common stock issued for services

-

-

-

-

-

-

-

0

0

Impairment of goodwill

-

-

-

-

-

-

1,919

0

-

Stock-based compensation

700

1,725

1,710

1,962

1,573

496

263

332

806

Forgiveness of loan payable

-

-

15,654

0

-

-

-

-

-

Non-cash impairment

-

-

-

1,500

0

-

-

-

-

Change in assets - (increase) decrease:
Restricted cash

-

-

-

-

-2,977

1,575

1,401

0

-

Receivables

-116

-139

121

11

-148

360

-767

359

-

Interest receivable

-

-

-

-

-

-

-

25

-

Prepaid expenses and other current assets

-152

223

158

132

-24

12

136

26

-

Other assets

-32

55

34

-8

14

29

5

8

-

Change in liabilities - increase (decrease):
Accounts payable and accrued expenses

-273

-347

-1,542

508

831

70

1,072

77

-

Accounts payable and accrued expenses, related party

-84

-68

-314

136

-81

9

184

4

-

Noncash interest expense

-

-

-

-

-

-

-

-

0

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

52

Other non-current assets

-

-

-

-

-

-

-

-

0

Accounts payable

-

-

-

-

-

-

-

-

105

Accrued expenses and other current liabilities

-

-

-

-

-

-

-

-

-587

Due to related party

-

-

-

-

-

-

-

-

-45

NET CASH USED IN OPERATING ACTIVITIES

-6,821

-13,862

-14,230

-14,454

-

-

-

-

-4,649

CASH FLOWS FROM INVESTING ACTIVITIES:
Deferred revenue

-

-

-

-

-

-

0

-

-

NET CASH USED IN OPERATING ACTIVITIES

-

-

-

-

-10,817

958

-6,144

-2,062

-

Purchase of marketable securities

6,002

18,011

18,986

17,997

17,989

0

226

4,214

-

Proceeds from sales and maturities of marketable securities

3,000

23,000

24,000

13,000

10,000

327

4,114

0

-

Purchases of property and equipment

0

316

32

191

129

162

56

13

1

Payments for leasehold improvements

-

-

-

1

21

23

-

-

-

Other investing activities, net

-

-

-

-

-

-

52

-

-

Proceeds from sale of assets

-

-

-

-

-

-

-

-

0

Payments for patents

-

-

-

-

-

-

-

-

0

NET CASH PROVIDED BY INVESTING ACTIVITIES

-

-

-

-

-8,140

141

3,778

-

-

Proceeds from reverse merger

-

-

-

-

-

-

-

0

-

Payments for patents

-

-

-

-

-

-

-

89

-

NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

-

-

-

-

-

-

-

-4,317

-

NET CASH PROVIDED BY INVESTING ACTIVITIES

-3,002

4,671

4,981

-5,191

-

-

-

-

-1

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes payable

-

-

-

-

-

-

-

-

0

Repayment of notes payable

-

-

-

-

-

-

-

-

0

Proceeds from exercise of stock options and warrants

-

-

-

-

-

-

-

-

13

Net proceeds from sale of common stock

9,174

6,714

11,073

13,864

16,446

0

-

-

0

Proceeds from exercise of pre-funded common stock warrants and warrants

0

0

-

-

-

-

-

-

-

Repurchase of fractional shares pursuant to reverse stock split

0

0

-

-

-

-

-

-

-

Proceeds from loan payable

-

-

500

4,750

0

5,200

3,925

0

-

Proceeds from stock options

2

139

6

-

-

-

0

-

-

Proceeds from stock awards, warrants, and options

-

-

-

13

45

4

-

-

-

Costs related to the issuance of preferred stock and warrants

-

-

-

-

-

-

-

0

-

NET CASH PROVIDED BY FINANCING ACTIVITIES

-

-

-

-

-

-

-

5,000

-

Proceeds from sale of common stock in private placement, net

-

-

-

-

-

-

-

-

2,298

NET CASH PROVIDED BY FINANCING ACTIVITIES

9,177

6,853

11,579

18,628

-

-

-

-

2,312

NET CASH PROVIDED BY FINANCING ACTIVITIES

-

-

-

-

16,491

5,205

3,925

-

-

NET DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

-645

-2,337

2,330

-1,016

-

-

-

-

-

NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH

-

-

-

-

-2,466

6,305

1,559

-1,380

-2,338

SUPPLEMENTAL DISCLOSURES:
Interest paid in cash

0

0

0

1

-

-

-

-

-

Interest paid in cash

-

-

-

-

2

0

0

0

0

Income taxes paid in cash

0

0

0

0

0

0

0

0

-

Warrants issued in satisfaction of accrued liability

-

-

-

-

-

-

-

-

0

Warrants issued to placement agent and investors in connection with private placements

-

-

-

-

-

-

-

-

1,083

Warrants issued to investors in connection with registered direct offering

-

-

-

-

-

-

-

-

0

Conversion of notes payable and interest to common stock

-

-

-

-

-

-

-

-

0

Common shares of SMI issued in reverse merger transaction

-

-

-

-

-

-

-

-

0